Patient Perspectives on Use of Video Telemedicine for Type 1 Diabetes Care in the United States during the COVID-19 Pandemic
The COVID-19 pandemic has resulted in widespread adoption of telemedicine for management of chronic conditions such as type 1 diabetes (T1D), but few data have been collected about the patient experience and perceived quality of care during this time. We surveyed members of the T1D Exchange patient...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-11-01
|
| Series: | Endocrines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-396X/2/4/40 |
| _version_ | 1797505154635792384 |
|---|---|
| author | Stephanie S. Crossen Crystal C. Romero Lindsey A. Loomba Nicole S. Glaser |
| author_facet | Stephanie S. Crossen Crystal C. Romero Lindsey A. Loomba Nicole S. Glaser |
| author_sort | Stephanie S. Crossen |
| collection | DOAJ |
| description | The COVID-19 pandemic has resulted in widespread adoption of telemedicine for management of chronic conditions such as type 1 diabetes (T1D), but few data have been collected about the patient experience and perceived quality of care during this time. We surveyed members of the T1D Exchange patient registry and online community regarding their experiences with and opinions about telemedicine care during the pandemic. Among 2235 survey respondents, 65% had utilized telemedicine. The most common reasons for adopting telemedicine were providers not offering in-person care (66%), concerns about the health risks of in-person care (59%), providers offering (52%) or insurance covering (19%) telemedicine for the first time, and local or state orders to stay home (33%). Among telemedicine users, 62% felt video care was as effective as or more effective than in-person care, and 82% hoped to use telemedicine in the future. The most-cited reason for non-use of telemedicine was that providers were not offering it (49%). Our findings highlight the role of telemedicine in maintaining access to T1D care during the COVID-19 pandemic. Respondents’ satisfaction with telemedicine and interest in its continued use signifies the need for ongoing access to this care modality and for the development of telemedicine best practices within T1D care. |
| first_indexed | 2024-03-10T04:14:34Z |
| format | Article |
| id | doaj.art-eca1ad4aedd640c8917fb71ab57d3589 |
| institution | Directory Open Access Journal |
| issn | 2673-396X |
| language | English |
| last_indexed | 2024-03-10T04:14:34Z |
| publishDate | 2021-11-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Endocrines |
| spelling | doaj.art-eca1ad4aedd640c8917fb71ab57d35892023-11-23T08:03:45ZengMDPI AGEndocrines2673-396X2021-11-012444945610.3390/endocrines2040040Patient Perspectives on Use of Video Telemedicine for Type 1 Diabetes Care in the United States during the COVID-19 PandemicStephanie S. Crossen0Crystal C. Romero1Lindsey A. Loomba2Nicole S. Glaser3Department of Pediatrics, University of California, Davis, Sacramento, CA 95817, USADepartment of Pediatrics, University of California, Davis, Sacramento, CA 95817, USADepartment of Pediatrics, University of California, Davis, Sacramento, CA 95817, USADepartment of Pediatrics, University of California, Davis, Sacramento, CA 95817, USAThe COVID-19 pandemic has resulted in widespread adoption of telemedicine for management of chronic conditions such as type 1 diabetes (T1D), but few data have been collected about the patient experience and perceived quality of care during this time. We surveyed members of the T1D Exchange patient registry and online community regarding their experiences with and opinions about telemedicine care during the pandemic. Among 2235 survey respondents, 65% had utilized telemedicine. The most common reasons for adopting telemedicine were providers not offering in-person care (66%), concerns about the health risks of in-person care (59%), providers offering (52%) or insurance covering (19%) telemedicine for the first time, and local or state orders to stay home (33%). Among telemedicine users, 62% felt video care was as effective as or more effective than in-person care, and 82% hoped to use telemedicine in the future. The most-cited reason for non-use of telemedicine was that providers were not offering it (49%). Our findings highlight the role of telemedicine in maintaining access to T1D care during the COVID-19 pandemic. Respondents’ satisfaction with telemedicine and interest in its continued use signifies the need for ongoing access to this care modality and for the development of telemedicine best practices within T1D care.https://www.mdpi.com/2673-396X/2/4/40telemedicinetype 1 diabetespatient-centered careCOVID-19 pandemic |
| spellingShingle | Stephanie S. Crossen Crystal C. Romero Lindsey A. Loomba Nicole S. Glaser Patient Perspectives on Use of Video Telemedicine for Type 1 Diabetes Care in the United States during the COVID-19 Pandemic Endocrines telemedicine type 1 diabetes patient-centered care COVID-19 pandemic |
| title | Patient Perspectives on Use of Video Telemedicine for Type 1 Diabetes Care in the United States during the COVID-19 Pandemic |
| title_full | Patient Perspectives on Use of Video Telemedicine for Type 1 Diabetes Care in the United States during the COVID-19 Pandemic |
| title_fullStr | Patient Perspectives on Use of Video Telemedicine for Type 1 Diabetes Care in the United States during the COVID-19 Pandemic |
| title_full_unstemmed | Patient Perspectives on Use of Video Telemedicine for Type 1 Diabetes Care in the United States during the COVID-19 Pandemic |
| title_short | Patient Perspectives on Use of Video Telemedicine for Type 1 Diabetes Care in the United States during the COVID-19 Pandemic |
| title_sort | patient perspectives on use of video telemedicine for type 1 diabetes care in the united states during the covid 19 pandemic |
| topic | telemedicine type 1 diabetes patient-centered care COVID-19 pandemic |
| url | https://www.mdpi.com/2673-396X/2/4/40 |
| work_keys_str_mv | AT stephaniescrossen patientperspectivesonuseofvideotelemedicinefortype1diabetescareintheunitedstatesduringthecovid19pandemic AT crystalcromero patientperspectivesonuseofvideotelemedicinefortype1diabetescareintheunitedstatesduringthecovid19pandemic AT lindseyaloomba patientperspectivesonuseofvideotelemedicinefortype1diabetescareintheunitedstatesduringthecovid19pandemic AT nicolesglaser patientperspectivesonuseofvideotelemedicinefortype1diabetescareintheunitedstatesduringthecovid19pandemic |